Zevra Therapeutics Inc (ZVRA)
NASDAQ
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-11 | Mr. Rahsaan W. ThompsonChief Legal Officer, Secretary & Compliance Officer | -1.79k | 20.27k | Automatic Disposition | 11.30 | 48.13k | -3.59% |
| 2026-03-24 | Mr. John B. BodeIndependent Director | 78.40k | 386.51k | Derivative Exercise and Retained Stock | 4.89 - 4.97 | 123.40k | 174.22% |
| 2026-02-07 | Mr. Neil F. McFarlanePresident, CEO & Director | 22.88k | 0.00 | Derivative Exercise and Retained Stock | - | 387.23k | 6.28% |
| 2026-02-07 | Mr. Neil F. McFarlanePresident, CEO & Director | -14.63k | 125.19k | Derivative Exercise and Sale | 8.56 | 387.23k | - |
| 2026-02-03 | Mr. Timothy J. SangiovanniSenior VP of Finance & Corporate Controller | -3.00k | 27.55k | Automatic Disposition | 9.18 | 29.59k | -9.21% |
| 2026-02-03 | Mr. Joshua M. SchaferChief Commercial Officer | -10.50k | 96.50k | Automatic Disposition | 9.19 | 62.28k | -14.43% |
| 2026-01-30 | Mr. Timothy J. SangiovanniSenior VP of Finance & Corporate Controller | 16.25k | 0.00 | Derivative Exercise and Retained Stock | - | 32.59k | 99.44% |
| 2026-01-30 | Mr. Timothy J. SangiovanniSenior VP of Finance & Corporate Controller | -1.75k | 15.44k | Derivative Exercise and Sale | 8.82 | 32.59k | - |
| 2026-01-30 | Mr. Rahsaan W. ThompsonChief Legal Officer, Secretary & Compliance Officer | 7.25k | 0.00 | Derivative Exercise and Retained Stock | - | 49.92k | 17.00% |
| 2026-01-30 | Mr. Rahsaan W. ThompsonChief Legal Officer, Secretary & Compliance Officer | -4.08k | 36.01k | Derivative Exercise and Sale | 8.83 | 49.92k | - |
| 2026-01-31 | Mr. Neil F. McFarlanePresident, CEO & Director | 142.33k | 0.00 | Derivative Exercise and Retained Stock | - | 364.35k | 64.11% |
| 2026-01-31 | Mr. Neil F. McFarlanePresident, CEO & Director | -91.00k | 853.43k | Derivative Exercise and Sale | 9.38 | 364.35k | - |
| 2026-01-30 | Mr. Joshua M. SchaferChief Commercial Officer | 43.29k | 0.00 | Derivative Exercise and Retained Stock | - | 72.78k | 146.82% |
| 2026-01-30 | Mr. Joshua M. SchaferChief Commercial Officer | -3.38k | 29.80k | Derivative Exercise and Sale | 8.83 | 72.78k | - |
| 2026-01-30 | Dr. Adrian QuartelChief Medical Officer | 6.80k | 0.00 | Derivative Exercise and Retained Stock | - | 9.72k | 232.64% |
| 2026-01-30 | Dr. Adrian QuartelChief Medical Officer | -4.53k | 40.04k | Derivative Exercise and Sale | 8.83 | 9.72k | - |
| 2025-12-31 | Mr. R. LaDuane Cliftonインサイダー | 92.15k | 0.00 | Derivative Exercise and Retained Stock | - | 143.52k | 179.42% |
| 2025-12-31 | Mr. R. LaDuane Cliftonインサイダー | -48.51k | 434.68k | Derivative Exercise and Sale | 8.96 | 143.52k | - |
| 2025-10-10 | Mr. Neil F. McFarlanePresident, CEO & Director | 30.50k | 0.00 | Derivative Exercise and Retained Stock | - | 222.02k | 15.93% |
| 2025-10-10 | Mr. Neil F. McFarlanePresident, CEO & Director | -19.50k | 210.91k | Derivative Exercise and Sale | 10.82 | 222.02k | - |
| 2025-09-12 | Ms. Tamara A. FavoritoIndependent Chair | 3.18k | 24.72k | 買い | 7.79 | 3.89k | 441.59% |
| 2025-09-12 | Dr. Alvin ShihIndependent Director | 20.00k | 157.80k | 買い | 7.89 | 20.00k | - |
| 2025-08-19 | Mr. John B. BodeIndependent Director | 5.00k | 45.83k | 買い | 9.17 | 45.00k | 12.50% |
| 2025-06-26 | Mr. Rahsaan W. ThompsonChief Legal Officer, Secretary & Compliance Officer | -24.00k | 221.00k | Automatic Disposition | 9.21 | 42.67k | -36.00% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。